Dan Smith

Company: Alkermes

Job title: Executive Director, Head of Translational Medicine

Seminars:

Transforming the Translational Validity of Preclinical Psychosis Models: Moving Beyond Dopamine-Focused Assays to Study New Anti-Psychosis Drug Mechanisms & Demonstrate Clinically Relevant Readouts 9:00 am

Current psychosis research often relies on pharmacological challenges, such as administering stimulants (e.g., amphetamine) or NMDA receptor blockers (e.g., MK21, PCP) to healthy brains. While these methods model certain aspects of psychosis, they may not fully capture the broader alterations seen in the disorder. However, they remain among the best available tools. Recent advancements using…Read more

day: Pre-Conference Day